DWTXDogwood Therapeutics Inc.Running, no new patients
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Chemotherapy Induced Neuropathic Pain · Chemotherapy Induced Pain Neuropathy · Chemotherapy Induced Pain
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 2
- Patients
- 240 (planned)
- Started
- Feb 21, 2025
- Main results expected
- Dec 2026
- Fully finished
- Dec 2026
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
NRS Pain
Measured over: From enrollment to end of study at 4 weeks
Safety Assessments
Measured over: From enrollment to end of study at 4 weeks
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT06848348 · record last updated 2026-09-16 · checked 2026-11-09 15:47 UTC